Sainalytics Clinical Research Solutions Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -51.57%
- Ebitda -51.83%
- Net Worth -71.32%
- Total Assets -35.53%
About Sainalytics Clinical Research Solutions
Sainalytics Clinical Research Solutions Private Limited (SCRSPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 December 2017 (Seven years and one month 16 days old ). Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Bcl Bioclinical Solutions Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhanu Bhashirin and Dudekula Afrin serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73100TG2017PTC121279
-
Company No.
121279
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Dec 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sainalytics Clinical Research Solutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhanu Bhashirin
|
Director | 18-Dec-2017 | Current |
|
Dudekula Afrin
|
Director | 28-Jun-2019 | Current |
Financial Performance of Sainalytics Clinical Research Solutions.
Sainalytics Clinical Research Solutions Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 51.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 71.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sainalytics Clinical Research Solutions?
Unlock access to Sainalytics Clinical Research Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Trida Clinical Research Private LimitedBhanu Bhashirin is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sainalytics Clinical Research Solutions?
Sainalytics Clinical Research Solutions has a workforce of 13 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sainalytics Clinical Research Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sainalytics Clinical Research Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
